This opportunity is no longer accepting applications.
grant PAR-22-091

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

This grant encourages applications for exploratory bioengineering research projects. It aims to support work demonstrating new capabilities or improvements in the quality, speed, effectiveness, functionality, cost, or accessibility of solutions for problems in various areas, including basic biomedical research, pre-clinical or clinical research, healthcare delivery, or accessibility.

The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, effic…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Cancer Institute
Program: SBIR

Awards & funding

Award Ceiling: $275,000
Award Amount: $275,000

Dates

Opportunity Released: January 11, 2022
Open for Submission: January 11, 2022
Submission Deadline: January 7, 2025
Application Window Closes: January 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.